Review began 04/15/2022 review ended 04/26/2022 published 04/27/2022 © copyright

HIGHLIGHTS

• who: Report and colleagues from the (UNIVERSITY) have published the research: Review began 04/15/2022 Review ended 04/26/2022 Published 04/27/2022 u00a9 Copyright, in the Journal: (JOURNAL) of April/27,/2022
• what: The study shows that a clinical trial with intravenous bevacizumab for patients with HHT is warranted.
• how: The criteria above are the basis for a diagnosis of HHT and give an indication for genetic testing to confirm a diagnosis i.e. if two out of four features are present in HHT-affected patients subsequent genetic testing is . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.